ESR1 and colonic neoplasm: Moreover, in human colon cancer, estrogen receptor (ER) signaling is documented as an inhibitor of the Wnt pathway [57], which has long been implicated in initiation and progression of colorectal cancer [58], however, the mechanism by which estrogen modulates Wnt signaling is currently unknown.